BRADY KELLY (See Remarks) sold 0.7% of their position (64.00 shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $291.20 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2026ACC: 0001193125-26-355734
Officer· See Remarks
Since Mar 2026
-64.00
Net shares
Net seller
$291.20
Total sold
1
Open market trades
0B · 1S
4
Total transactions
181.00 acquired · 245.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+181.00
Price / share
—
Trade value
—
% of position
2.1%
8/15/2026
8.56K→8.74K
Common Stock
Direct
Shares
−64.00
Price / share
$4.55
Trade value
$291.20
% of position
0.7%
8/17/2026
8.74K→8.68K
Total
Net shares
+117.00
Net value
-$291.20
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2026 | M · Option Exercise | +181.00 | — | — | 2.1% | 8.56K | 8.74K |
| Common Stock Direct | 8/17/2026 | S · Sale | −64.00 | $4.55 | $291.20 | 0.7% | 8.74K | 8.68K |
| Total | +117.00 | -$291.20 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
90.00 shares
Shares
−90.00
Strike price
Held after
179.00
Exercisable
—
8/15/2026
Restricted Stock Units
Direct
Converts to
Common Stock
91.00 shares
Shares
−91.00
Strike price
Held after
548.00
Exercisable
—
8/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock90.00 shares | 8/15/2026 | M · Option Exercise | −90.00 | — | 179.00 | |
| Restricted Stock Units Direct | Common Stock91.00 shares | 8/15/2026 | M · Option Exercise | −91.00 | — | 548.00 |